Step by Step
S
S. aureus identification — catalase-positive, coagulase-positive
Staphylococcus aureus is catalase-positive (distinguishing it from Streptococcus) and coagulase-positive (distinguishing it from coagulase-negative staph species, or CoNS), and characteristically forms golden colonies on blood agar.
Example: a lab technician using the coagulase test specifically to distinguish S. aureus from other, less pathogenic coagulase-negative staph species growing on the same culture plate.
T
Key toxins — TSST-1, exfoliatin, PVL
S. aureus produces several important toxins: TSST-1 (causing toxic shock syndrome), exfoliatin (causing scalded skin syndrome), and PVL (causing necrotizing pneumonia).
Example: a patient with widespread skin peeling and blistering being diagnosed with staphylococcal scalded skin syndrome, caused specifically by the exfoliatin toxin.
M
MRSA — the mecA gene and PBP2a
MRSA (Methicillin-Resistant Staphylococcus aureus) carries the mecA gene, which encodes an altered penicillin-binding protein called PBP2a. This altered protein has low affinity for beta-lactam antibiotics, making MRSA resistant to ALL penicillins and cephalosporins.
Example: a beta-lactam antibiotic failing to treat an MRSA infection because PBP2a, the altered target protein encoded by mecA, simply doesn't bind these drugs effectively.
R
Treating MRSA — vancomycin, daptomycin, linezolid
Because MRSA is resistant to all beta-lactams, treatment requires alternative antibiotics that work through different mechanisms: vancomycin, daptomycin, or linezolid.
Example: a patient with a confirmed MRSA infection being switched to vancomycin, since standard beta-lactam antibiotics would be completely ineffective against this resistant strain.
Applied Walkthrough
1
A patient's Staph infection fails to respond to a standard beta-lactam antibiotic, and further testing confirms the strain carries the mecA gene.
2
Ask: what does the mecA gene specifically confer? Production of PBP2a, an altered penicillin-binding protein with low affinity for beta-lactam antibiotics — this is exactly what defines MRSA and explains the treatment failure.
3
Because PBP2a confers resistance to ALL penicillins and cephalosporins (not just methicillin specifically, despite the name), the patient needs to be switched to an entirely different class of antibiotic.
4
The physician switches to vancomycin, one of the standard alternative treatments for MRSA, since it works through a different mechanism unaffected by the PBP2a resistance mutation.
Exam Application
Exams test whether you know the identification tests for S. aureus (catalase-positive, coagulase-positive), the key toxins and their associated syndromes (TSST-1/toxic shock, exfoliatin/scalded skin, PVL/necrotizing pneumonia), and specifically the mecA/PBP2a mechanism behind MRSA resistance, along with appropriate alternative treatments.
⚠ Common Trap
The most common trap is assuming MRSA is only resistant to methicillin specifically, based on the name. In reality, the mecA gene's PBP2a product confers resistance to ALL penicillins and cephalosporins broadly, not just methicillin — the name is a historical artifact from when methicillin was the specific drug used to first identify this resistance pattern.
✓ Quick Self-Check
1. What two lab tests confirm S. aureus identification?
Catalase-positive and coagulase-positive.
Tap to reveal / hide
2. What syndrome does the TSST-1 toxin cause?
Toxic shock syndrome.
Tap to reveal / hide
3. What syndrome does the exfoliatin toxin cause?
Staphylococcal scalded skin syndrome.
Tap to reveal / hide
4. What does the mecA gene encode, and what effect does it have?
PBP2a, an altered penicillin-binding protein with low affinity for beta-lactams, conferring resistance to all penicillins and cephalosporins.
Tap to reveal / hide
5. Name two antibiotics used to treat MRSA.
Vancomycin, daptomycin, or linezolid (any two).
Tap to reveal / hide